Vimarsana
Biggest News Aggregation in the World

Page 2 - Adoshell Islets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adoshell Islets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adoshell Islets Today - Breaking & Trending Today

ADOCIA Reports its Cash Position and Revenue for the Third Quarter of 2022 and Provides Business Updates - Vimarsana News

ADOCIA Reports its Cash Position and Revenue for the Third Quarter of 2022 and Provides Business Updates

A cash position of EUR 20.1 million as of September 30, 2022 An increase in collaboration revenues of EUR 2.3 million for the quarter, compared to EUR 0.4 million for the same period last

Number of Shares and Voting Rights of ADOCIA as of September 30th, 2022 - Vimarsana News

Number of Shares and Voting Rights of ADOCIA as of September 30th, 2022

Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF")

ADOCIA Announces First Half 2022 Financial Results and Provides a Business Update - Vimarsana News

ADOCIA Announces First Half 2022 Financial Results and Provides a Business Update

Adocia management will hold a Webcast (in French) on Tuesday, September 20, 2022, at 6:00 pm CEST Net profit for the six months ended June 30, 2022, of EUR 4.25 million compared to a loss of EUR

Adocia: ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell Islets for the Treatment of Type 1 Diabetes - Vimarsana News

Adocia: ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell Islets for the Treatment of Type 1 Diabetes

AdoShell Islets regulated glycemic control in immunocompetent diabetic animals in a 132-day trial without the use of insulin or immunosuppression. These results will be presented at the upcoming

ICER Dumps on Wegovy Cost-Effectiveness; Kerendia Label Update; Synthetic Embryos? - Vimarsana News

ICER Dumps on Wegovy Cost-Effectiveness; Kerendia Label Update; Synthetic Embryos?

News and commentary from the endocrinology world